Dresner Partners, the leading provider of investment banking services to the fertility (IVF) sector in the USA, advised RADfertility in its sale to CCRM Fertility

Dresner Partners, Mergers Alliance partner in the USA advised RADfertility, state-of-the-art fertility care provider to the Mid-Atlantic area, in its sale to CCRM Fertility, a global pioneer in fertility treatment, research and science in the USA.

Founded in 1995 by Barbara A. McGuirk, MD, RADfertility provides state-of-the-art fertility care to the Mid-Atlantic area, with three locations in Delaware including Newark, Wilmington and Dover.  The assisted reproductive technologies (ART) program was started by Ronald F. Feinberg, MD, PhD in 1997.  The practice now has six board certified fertility doctors who utilize ART and advanced minimally-invasive surgical techniques to provide patients with high rates of success for in vitro fertilization (IVF). 

CCRM Fertility is a global pioneer in fertility treatment, research and science.  Founded by Dr. William Schoolcraft 35 years ago, CCRM Fertility specializes in the most advanced fertility treatments, with deep expertise in IVF, fertility testing, egg freezing, preimplantation genetic testing, third party reproduction and egg donation.  CCRM Fertility leverages its own data and a dedicated team of in-house reproductive endocrinologists, embryologists and geneticists to deliver industry-leading outcomes.  CCRM Fertility proudly serves 12 metropolitan areas with 36 locations in North America, including Atlanta, Boston, Dallas-Fort Worth, Delaware, Denver, Houston, New Jersey, New York, Northern Virginia, Minneapolis, Orange County, San Francisco Bay Area and Toronto.

Commenting on the transaction, Drs. McGuirk and Feinberg said, “We would like to thank the Dresner team for their expertise and professionalism throughout the entire process.  Joining forces with CCRM Fertility will enable us to execute our long-term strategic plan of establishing additional clinical sites, serving more patients, and offering the same treatment to patients that we would want for our friends and loved ones.”  Dr. McGuirk will continue to serve as Director of Reproductive Surgery, and Dr. Feinberg will serve as IVF Director and Chief Medical Officer for the practice.

Mitchell Stern, Managing Director and Head of the Healthcare Group at Dresner Partners said, “We enjoyed working closely with Dr. McGuirk, Dr. Feinberg and the rest of the RADfertility team.  Both RADfertility and CCRM are closely aligned with award-winning physicians, use of innovative technology, state-of-the art laboratories, and best-in-class patient care.  The synergies between the two organizations will further enhance and expand the reach of the CCRM network.” 

Dresner Partners is a leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Pinnacle Fertility, the sale of Dominion Fertility to Pinnacle Fertility, the sale of Center of Reproductive Medicine to US Fertility, the sale of IVF1 to Pinnacle Fertility, the sale of Fertility Institute of New Jersey & New York to Axia Women’s Health, and the sale of RADfertility to CCRM Fertility.

Related News